August 2026
M	T	W	T	F	S	S
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Vidyashri Hattigoudar: Essentials and Management of Hemophilia A

AI Generated

Aug 25, 2026, 14:31

Vidyashri Hattigoudar: Essentials and Management of Hemophilia A

Vidyashri Hattigoudar, Clinical Manager at Shakti Hospital, shared a post on LinkedIn:

“Hemophilia A-Understanding the Bleeding Disorder

Hemophilia A is a rare inherited bleeding disorder caused by a deficiency or reduced activity of clotting factor VIII (FVIII).

Normally, clotting factors work together to stop bleeding. In Hemophilia A, insufficient FVIII makes it difficult for the blood to form a stable clot.

Common Features

Prolonged bleeding after injuries, dental procedures, or surgery
Easy bruising
Recurrent bleeding into joints, especially knees, ankles, and elbows
Bleeding into muscles and soft tissues
In severe cases, bleeding may occur spontaneously

Why does it happen?

Hemophilia A is usually caused by a change (mutation) in the F8 gene, which provides instructions for making factor VIII. It is typically X-linked, meaning it mainly affects males, while females may be carriers.

Treatment and Management

Treatment aims to prevent and control bleeding. Options may include:

Factor VIII replacement therapy
Non-factor therapies such as emicizumab for appropriate patients
Treatment plans tailored according to severity and individual needs
Regular monitoring and comprehensive hemophilia care

Key message: Hemophilia A is a lifelong condition, but with early diagnosis, appropriate treatment, and proper care, people with Hemophilia A can live active and fulfilling lives.”

Vidyashri Hattigoudar: Essentials and Management of Hemophilia A